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including pharmacologic therapy, antioxidant therapy, the
local infusion of heparin, and gene-directed therapy of ade-
noviral vectors,3-6 have yet to be widely used and accepted
as methods for preventing IH. One possible impediment
to the widespread use of the various therapies shown to be
effective in in vitro and in animal studies is the expense and
complexity in the practical utility of applying these thera-
pies on a daily basis.
On the other hand, oxygen is widely available with a
long history of relative safety. Only recently, short-term
supplemental oxygen therapy has been found to prevent
surgical wound infection after colorectal surgery. With
such a widely available therapeutic modality, oxygen, as a
preventive therapy for IH, has not fully been explored.
In 1944 Hueper7 first suggested that artery wall
hypoxia was involved in artery wall pathology. Since then,
several others have independently demonstrated depressed
partial pressure of oxygen (PO2) levels in the artery wall
when exposed to conditions known to cause atherosclero-
sis or IH.8,9 Current research has shown that artery wall
hypoxia occurs after placement of a prosthetic vascular
graft (PVG)–to-artery anastomosis, and that this hypoxia
is associated with increased smooth muscle cell prolifera-
tion.10,11 The next appropriate step, then, is to determine
whether the administration of supplemental oxygen could
inhibit or decrease IH formation.
Intimal hyperplasia (IH) is a pathologic response to
vascular injury, which complicates vascular bypass graft
procedures by causing stenoses, graft failures, and reoper-
ation.1 Because of the impact on quality of life, medical
costs, and the potential loss of life and limb, researchers in
several laboratories are actively examining the causes and
mechanisms of IH. The formation of IH is generally
thought to occur as a result of endothelial cell injury, vas-
cular smooth muscle cell migration, cell proliferation, and
extracellular matrix formation.2
The effective treatment and prevention of IH in clini-
cal practice continue to elude vascular surgeons. Strategies,
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Purpose: The purpose of this study was to determine whether the administration of 40% supplemental oxygen (O2) will
decrease cellular proliferation and intimal hyperplasia (IH) at a prosthetic vascular graft (PVG)–to-artery anastomosis.
Methods: Twenty New Zealand white rabbits underwent placement of a 3-mm polytetrafluoroethylene graft in their
infrarenal aorta. Four groups of five rabbits were placed either in a normoxic (21%) environment or in a 40% supple-
mental O2 environment for 7 or 42 days. Twenty-four hours before the rabbits were humanely killed for aortic graft
harvest, BrDU (5-bromo-2´-deoxyuridine) was injected into the rabbits intraperitoneally. Image analysis (Bioquant)
morphometrics were used to measure cells with BrDU staining and intimal areas at the distal anastomosis. Cellular pro-
liferation is defined as positively staining BrDU cells divided by all cells in the artery wall. IH is reported as a ratio
between the intimal area and the medial area to standardize the varying aortic size and degree of aortic fixation among
rabbits. The Student t test was used to compare cellular proliferation and IH between control and O2-treated rabbits.
Results: Cellular proliferation in the intima at 7 days was significantly reduced in the O2-treated animals (1.7% ± 1%)
versus the control animals (28.6% ± 3%) (P = .0001). The cellular proliferation in the intima at 42 days returned to
preoperative levels in the O2-treated group (0.15%) and in the control group (0.11%) (P = not significant). IH at 7
days was minimal, and no difference between the O2-treated group (0.017 ± .006) and the control group (0.009 ± .03)
(P = not significant) was found. IH was significantly reduced at 42 days in the O2-treated animals (0.031 ± .012) when
compared with the control animals (0.193 ± .043) (P = .006).
Conclusions: Supplemental O2 (40%) significantly reduces cellular proliferation and IH at the distal anastomosis of a
PVG-to-artery anastomosis in the rabbit model. (J Vasc Surg 2001;33:608-13.)
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We hypothesize that artery wall hypoxia is a key fac-
tor in causing IH through increased cellular proliferation
at a PVG-to-artery anastomosis and that supplemental
oxygen may prevent IH. The purpose of this study was to
determine whether 40% supplemental oxygen treatment
would decrease cellular proliferation and anastomotic IH
at the distal anastomosis of a PVG-to-artery anastomosis
in the rabbit.
METHODS
Animal model. Twenty rabbits, five in each group, were
assigned to one of the four following arms of the study: 7-
day control, 7-day supplemental oxygen, 42-day control,
and 42-day supplemental oxygen. Immediately after place-
ment of the PVG-to-artery anastomosis, the rabbits were
assigned to a control cage (21% oxygen environment) or to
an oxygen chamber (40% oxygen environment) designed
and built by Plas Laboratories (Lansing, Mich). These
chambers were deigned to regulate the environmental oxy-
gen content (40%) and relative humidity (50%). New
Zealand white rabbits were conditioned to their environ-
ment and fed standard rabbit chow and water as desired at
least 2 weeks before the procedure. All rabbits tolerated the
oxygen chambers well, and oxygen-supplemented rabbits
were exposed to a normoxic environment (inspired oxygen:
21%) for 1 to 2 hours a day to allow for daily oxygen cham-
ber cares such as food, water, and bedding changes. All ani-
mal procedures conducted during the study were in
accordance with an animal use protocol approved by the
Minneapolis Veterans Affairs Institutional Animal Care and
Use Committee.
Placement of the PVG. After 2 weeks acclimatization,
rabbits were anesthetized with ketamine (40 mg/kg) and
xylazine (5 mg/kg) intramuscularly and blindly intubated
with a 3-mm endotracheal tube. Rabbits then received
150,000 units of penicillin subcutaneously, a 24-gauge
intravenous catheter was placed in a marginal ear vein, and
the rabbits were placed on a water-circulating heating pad
to maintain core body temperature. Inhalation anesthesia
of 1% to 1.5% isoflurane was used to maintain rabbits under
general anesthesia for the duration of the operation. Under
2.5×-loupe magnification and aseptic technique, a midline
incision from the xiphoid bone to the pubis bone was used
to expose the infrarenal aorta. The intestines were retracted
to the right, and the peritoneum was dissected to free the
distal 2 cm of aorta. The rabbits then received 250 U/kg
of intravenous heparin sodium 3 minutes before cross-
clamping of the aorta.
The infrarenal aorta, 2 cm proximal to the aortic bifur-
cation, was clamped with two bulldog clamps, and a lon-
gitudinal incision in the aorta was made with an 11-blade
scalpel. The incision was lengthened to 3 mm in size with
iris scissors. A prosthetic 3-mm polytetrafluoroethylene
graft (W.L. Gore Associates, Inc, Flagstaff, Ariz), 3.5 cm
in length, was then sewn in an end of graft to side of artery
fashion with a running 7-0 Prolene suture. Once the prox-
imal anastomosis was complete, the above steps were then
repeated for the distal anastomosis. After graft placement,
a 4-0 silk tie was placed just proximal to the distal anasto-
mosis to ensure 100% blood flow through the graft, a
functional end-to-end anastomosis.
BrdU administration and harvesting of the aortic
graft. Twenty-four hours before the rabbits were
humanely killed, BrdU (5-bromo-2´-deoxyuridine) (100
mg/kg; Sigma Chemical Co, St Louis, Mo) was adminis-
tered intraperitoneally. Rabbits were then euthanized with
an overdose of pentobarbital. The infrarenal aorta and the
inferior vena cava were cannulated with 20-gauge
catheters. Each rabbit was flushed with normal saline and
was exsanguinated. The aorta and the aortic graft were
perfusion fixed at 300 mm Hg of pressure with
Karnovsky’s solution for 10 minutes.8 The aorta was har-
vested and prepared for histologic analysis. The slide spec-
imens were then stained with hematoxylin and eosin,
Verhoff-van Gieson, and elastin stains.
Sample processing and BrdU staining. The BrdU
staining was performed according to the suggested proce-
dures of the Zymed BrdU staining kit (Zymed Laboratories,
San Francisco, Calif). Each specimen was embedded in
paraffin, and 4-µm thick sections were cut on a microtome.
The sections were cut transversely, 1 to 2 mm distal to the
distal anastomosis, and longitudinally to demonstrate the
lumen of the artery and the graft loop. Sections were
mounted on glass slides and dried in a 60°C oven for 30 to
60 minutes. They were then deparaffinized in xylene and
rehydrated with a series of ethanols. Endogenous peroxidase
activity was quenched in peroxidase-quenching solution for
10 minutes, and the slides were rinsed in phosphate-
buffered saline (PBS). Sections were treated with trypsin for
10 minutes in a moist chamber at 37°C. The sections were
incubated with denaturing solution for 30 minutes to
increase the accessibility of the antigen. The sections were
treated for nonspecific labeling with blocking solution for 10
minutes. Biotinylated mouse anti-BrdU reagent was applied
to the sections for 60 minutes at room temperature. The
sections were rinsed again in PBS and incubated for 10 min-
utes with streptavidin-peroxidase reagent. After rinsing, the
color was developed by incubation with DAB (3,3´-
diaminobenzidine) mixture with the aid of a microscope.
Sections were counterstained with hematoxylin, washed in
tap water, transferred into PBS until the nuclei were blue
(approximately 2-3 minutes), and then rinsed in distilled
water. Slides were dehydrated in graded alcohol solutions,
cleared in xylene, and cover slipped.
Image analysis (Bioquant) morphometric measure-
ment of BrdU labeling and IH. Cells that incorporated
BrdU were identified as having a distinctive brown pig-
ment within their nuclei. A Zeiss microscope with a digi-
tized camera attachment (Oberkochen, Germany) fed
images directly into a personal computer–based micro-
processor. Image analysis (Bioquant) morphometrics pro-
gram was used to count all BrdU-labeled cells and all
other cells within a microscopic field. This process was
repeated until the entire circumference of the artery wall
was evaluated. Cellular proliferation was defined as all cells
positively staining for BrdU divided by all cells present
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within the artery wall. Cellular proliferation is reported in
percent units (positively stained BrdU cells/all cells).
The image analysis (Bioquant) morphometrics pro-
gram was also used for measuring the intimal area (IA) to
medial area (MA) ratio. The digital camera was calibrated
by measuring a known distance on the microscope stage.
The intimal and medial boundaries were then marked, and
the IA and the MA were then automatically calculated.
The standardization of IA to MA was performed because
of varying animal aortic sizes and the extent of fixation.
Artery blood gas analysis. Arterial blood gases were
obtained from the central ear artery while the rabbits were
housed in the oxygen chambers to ensure proper chamber
function. We could then document arterial blood oxygen
content.
Artery wall oxygen tension measurements. Artery
wall oxygen tensions were directly measured with a 
platinum-iridium microelectrode 2 mm distal to the distal
anastomosis at 10-µm intervals with a chemical microsen-
sor (Model 1201; Diamond General Corp, Ann Arbor,
Mich). The measurement, 2 mm distal to the distal anas-
tomosis, was performed because the degree of scarring
makes preservation of the vasa vasorum unlikely. Also, if
measurements were taken at the anastomosis, electrode
Fig 1. Cell proliferation in PVG-to-artery anastomosis. Immunoperoxidase staining of BrdU-labeled cells. Darkly stained
nuclei (arrows) represent positive staining cells. Seven-day oxygen treated rabbit (Biotinylated mouse anti-BrdU, original
magnification × 200). 
Fig 2. Seven-day oxygen-treated rabbit (Biotinylated mouse anti-BrdU, original
magnification ×200).
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breakage would occur more frequently because contact
with suture material would cause breakage.
Rabbits were exposed to either a 21% oxygen environ-
ment (control) or a 40% oxygen environment during artery
wall oxygen tension measurements. The oxygen tension
measurements followed a curvilinear pattern where the
nadir was found to be two thirds internal to the adventitial
layer. In this report, arterial PO2 levels at the adventitial
(outer) layers are presented to summarize the change in
oxygen tension values at the artery anastomosis. Complete
artery wall oxygen tension profiles at varying oxygen con-
centrations at different time points have been published
elsewhere.10,11
Statistical analysis. All data were expressed as mean ±
SEM. The Student 2-tailed t test with Excel 98 for the
Macintosh computer (Microsoft, Redmond, Wash) was
used to compare cellular proliferation and IH between the
control rabbits and rabbits treated with supplemental oxy-
gen. A P value less than .05 was considered significant.
RESULTS
During the follow-up period, no animals had compli-
cations of an occluded graft, which would be demon-
strated by progressive paresis and subsequent paralysis.
The PO2 in the arterial blood gas analysis was 297 ± 17
mm Hg in the oxygen-treated animals and 87 ± 4 mm Hg
in the control animals. Artery wall oxygen tension levels
were directly measured 2 mm distal to the distal anasto-
mosis. The results of artery wall tension levels at the
adventitial layers demonstrated a nadir PO2 level of 25.4 ±
2.6 mm Hg in the 7-day control rabbits and a nadir PO2
level of 98.3 ± 9.3 mm Hg in the 7-day supplemental oxy-
gen O2-treated rabbits. The oxygen tension levels in the
pretreated rabbits, where no graft anastomosis was placed,
were 60 ± 2 mm Hg. A nadir PO2 level of 25 ± 1.9 mm
Hg was found in the 42-day control rabbits, and a nadir
PO2 level of 197 ± 10.3 mm Hg was found in the 42-day
O2-treated rabbit. Cellular proliferation at 7 days was sig-
nificantly higher in the control animals, with 28.6% ± 3%
(Fig 1), when compared with the oxygen-treated animals,
with 1.7% ± 1% (P = .0001, Fig 2). The cellular prolifera-
tion rates were no different at day 42 and returned to pre-
operative levels with 0.13% cellular proliferation in
controls compared with 0.15% cellular proliferation in the
O2-treated animals (P = not significant).
IH was no different between control animals with an
IA/MA ratio of 0.017 ± .006 and O2-treated animals with
an IA/MA ratio of 0.009 ± .003 at day 7 (P = not signif-
icant). However, at day 42, a significant decrease in
IA/MA ratio was found in the O2-treated animals.
Control animals had an IA/MA ratio of 0.193 ± 0.043
(Fig 3) compared with the O2-treated animals, which had
a ratio of 0.031 ± 0.012 (P = .006, Fig 4).
DISCUSSION
This is the first in vivo evidence that supplemental oxy-
gen can control cellular proliferation and IH at a PVG-to-
artery anastomosis. This finding is significant in that
supplemental oxygen is a readily available treatment
modality with a long history of relative safety. If IH can be
controlled by such a simple treatment, significant morbid-
ity, mortality, and health care resources can be saved in
terms of preventing graft stenosis, occlusion, reoperation,
and limb loss.
In previous work in our laboratory, we have demon-
strated that the creation of a PVG-to-artery anastomosis
Fig 3. IH in PVG-to-artery anastomosis. A 42-day control rabbit (hematoxylin and eosin stain, original magnification
×200). IEL, Internal elastic lamina.
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results in significant artery wall hypoxia, which resolves in
42 days.11 More important, after the first 7 days after PVG
placement, the artery wall is most hypoxic, which correlated
with significantly increased smooth muscle cell prolifera-
tion.10 Although an association between artery wall hypoxia
and smooth muscle cell proliferation was established, a
cause and effect relationship between hypoxia and smooth
muscle proliferation still needs to be elucidated.
In this study, we showed that artery wall hypoxia plays
a role in causing IH formation through increased cellular
proliferation. However, no clear mechanism has been pro-
posed to explain how supplemental oxygen can alter artery
wall pathology in cellular proliferation and IH.
One possibility may be that supplemental oxygen is
responsible for increased free radical formation and subse-
quent oxidative stress at the anastomotic site prevents cel-
lular proliferation. The presence of reactive oxygen species
through the administration of hydrogen peroxide in cell
culture has been shown to induce vascular smooth muscle
cell apoptosis in a dose-dependent manner through the
formation of hydroxyl radicals.12 Similarly, radiation ther-
apy, both external beam and catheter directed, has also
been proposed as another therapy in preventing IH
through free radical formation.13
Another possible effect of supplemental oxygen may
actually be an antioxidant one. From previous studies, it
has been shown that the placement of a PVG-to-artery
anastomosis causes artery wall hypoxia. In rabbits with-
out a PVG anastomosis (preoperative values), the artery
wall oxygen tensions ranged from 50 to 60 mm Hg. In
rabbits with a PVG anastomosis, the artery wall oxygen
tensions ranged from 20 to 25 mm Hg.10 After the
administration of 40% supplemental oxygen, artery wall
oxygen tensions were brought to supernormal levels of
100 to 200 mm Hg. Whether the increases in artery wall
oxygen tension levels are more physiologic and reduce
oxidative stress at the vascular anastomosis needs to be
further elucidated. High concentrations of oxygen are
what is considered to be the cause of oxidative stress, but
it is also important to remember that low concentrations
of oxygen can also cause oxidative stress through hypoxia
and cell injury.
If, indeed, supplemental oxygen acts as an antioxidant
at a PVG anastomosis, this would be consistent with other
investigators’ findings that antioxidants can prevent cellu-
lar proliferation and IH. For instance, α-tocopherol (vita-
min E) has been found to inhibit vascular smooth muscle
cells in vitro through the inhibition of the protein kinase
C activity.14 All-trans-retinoic acid (vitamin A analog), 
has also been implicated in reducing IH in the rabbit
model.15
More recently, however, greater attention has been
paid to the role of nitric oxide (NO) in the prevention of
IH. NO is generated from the oxidation of the terminal
nitrogen group on the amino acid, L-arginine. This oxida-
tion process is facilitated by a single enzyme nitric oxide
synthase (NOS). The overall reaction is as follows:
L-arginine + O2 ––NOS––––––→ NO + L-citrulline
The precise role of NOS in the formation of NO is not
completely understood. Nevertheless, several studies have
shown that NO is an important modulator of vascular
smooth muscle cell migration16 and proliferation.17
Researchers in several laboratories have induced NO con-
centrations with L-arginine supplementation, which has
subsequently been shown to decrease IH.4,18,19 Other
proposed methods to increase NO synthesis have been 
to modulate the NOS enzyme through adenoviral vector
transfection in vivo20 or through ex vivo adenoviral-
mediated NOS gene transfer to arterial or venous vessels.6
Fig 4. A 42-day oxygen-treated rabbit (hematoxylin and eosin, original magnification ×200). IEL, Internal elastic lamina.
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Either the addition of L-arginine through diet or NOS
production through adenoviral transfection has been
shown to decrease IH through increased NO production.
Because oxygen plays an important role in the oxidation
reaction to increase NO levels, it may be possible to
achieve the same goals of increased NO production. The
increased NO concentration, in turn, can decrease cellular
proliferation and decrease IH through supplemental oxy-
gen. Further investigation is necessary to determine
whether oxygen is a rate-limiting substrate in NO produc-
tion. On the basis of results presented here, the addition
of oxygen does affect a change in vivo.
As mentioned previously, oxygen has been consid-
ered relatively safe, widely available, inexpensive, and
much simpler to apply as therapy in preventing IH than
that proposed by other investigators. Since the classic
19th century experiments by Paul Bert and Lorraine
Smith demonstrating that oxygen in high concentrations
was toxic to healthy mammalian lungs,21 oxygen use for
human use has been under investigation. A review of
several prospective and retrospective studies has shown
that multiday exposure to oxygen concentrations of 
55% or less does not significantly impair pulmonary
function in both normal healthy volunteers and human
patients.22
In 1934, Richards and Barach23 showed that exposure
of 40% to 50% oxygen concentrations in patients with
advanced heart failure and pulmonary disease and in two
healthy volunteers for 5 days to 7 months showed little or
no deleterious effects. Cardiac patients demonstrated an
improved circulatory function, and in the pulmonary
patients, improvement in arterial oxygen saturation was
noted, as well as improved ambulatory activity. The two
healthy volunteers experienced no adverse effects.23 In
1927, Campbell and Poulton reported several years’ work
on the effects of continuous residence in a 40% oxygen
chamber on patients with dyspnea. Most patients
improved, as evidenced by less dyspnea, less cough and
sputum, increased appetite, and weight gain.
As the oxygen concentrations were increased beyond
50% in human patients at varying amounts of time, vary-
ing degrees of pulmonary toxicity were seen. From these
studies, a practical asymptote of an inspired PO2 of 50% for
pulmonary oxygen tolerance was developed.22
CONCLUSIONS
Forty percent of supplemental oxygen significantly
reduces cellular proliferation and IH at the distal anasto-
mosis of a PVG-to-artery anastomosis in the rabbit model.
These findings suggest that the short-term administration
of supplemental oxygen may be a simple, safe, and inex-
pensive method to control IH at a PVG-to-artery anasto-
mosis.
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